Cellebrite DI Ltd.
CLBT
$17.09
$0.482.89%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 23.46% | 22.88% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 23.46% | 22.88% | |
| Cost of Revenue | -- | -- | 10.01% | 3.68% | |
| Gross Profit | -- | -- | 26.36% | 27.29% | |
| SG&A Expenses | -- | -- | 14.70% | 13.05% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 11.42% | 8.95% | |
| Operating Income | -- | -- | 276.18% | 1,254.70% | |
| Income Before Tax | -- | -- | -164.39% | -484.04% | |
| Income Tax Expenses | -- | -- | 56.20% | 93.25% | |
| Earnings from Continuing Operations | -- | -- | -153.37% | -551.77% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -153.37% | -551.77% | |
| EBIT | -- | -- | 276.18% | 1,254.70% | |
| EBITDA | -- | -- | 155.28% | 299.91% | |
| EPS Basic | -- | -- | -118.21% | -705.57% | |
| Normalized Basic EPS | -- | -- | -47.96% | -200.28% | |
| EPS Diluted | -- | -- | -109.85% | -772.68% | |
| Normalized Diluted EPS | -- | -- | -45.39% | -205.65% | |
| Average Basic Shares Outstanding | -- | -- | 5.26% | 4.68% | |
| Average Diluted Shares Outstanding | -- | -- | 4.49% | 2.53% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |